CRF Health Announces Global Partnership with Vodafone
CRF Health, a global provider of electronic Clinical Outcome Assessment solutions for the life sciences industry, announced a new partnership with Vodafone.
CRF Health, a global provider of electronic Clinical Outcome Assessment (eCOA) solutions for the life sciences industry, announced a new partnership with Vodafone. CRF Health will use Vodafone’s global Machine-to-Machine (M2M) platform to offer an enhanced service to clinical trial operators and their patients. The agreement provides for mobile data sending in clinical trials using the TrialMax® eCOA platform. Clinical trial sponsors running global studies will receive reliable connectivity, instant access, security and integration to data through Vodafone’s global network.
Read the full release here.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
